Skip to main content

Table 1 The incidence of CLL in 1990 and 2019 and its temporal trends

From: The global burden and attributable risk factors of chronic lymphocytic leukemia in 204 countries and territories from 1990 to 2019: analysis based on the global burden of disease study 2019

 

1990

2019

1990–2019

Incident cases

No*102 (95% CI)

ASIR/100,000

No. (95% CI)

Incident cases

No*102 (95% CI)

ASIR/100,000

No. (95% CI)

EAPC

No. (95% CI)

Overall

405.37 (371.18–427.52)

0.76 (0.69–0.80)

1034.67 (934.64–1189.42)

1.34 (1.21–1.54)

1.86 (1.79–1.92)

Sex

     

 Male

215.53 (187.96–229.36)

0.80 (0.70–0.85)

552.83 (488.69–665.21)

1.42 (1.26–1.71)

1.78 (1.71–1.85)

 Female

189.85 (175.20–204.20)

0.71 (0.66–0.77)

481.84 (427.87–552.37)

1.25 (1.11–1.43)

1.93 (1.86–1.99)

Socio-demographic factor

     

 High SDI

236.29 (216.67–252.13)

2.87 (2.64–3.07)

443.87 (384.09–545.65)

4.38 (3.79–5.38)

1.11 (1.08–1.15)

 High-middle SDI

102.93 (92.68–112.12)

0.89 (0.81–0.97)

306.56 (276.18–343.40)

2.14 (1.93–2.40)

3.13 (3.07–3.18)

 Middle SDI

31.21 (26.08–36.15)

0.18 (0.15–0.21)

154.59 (135.14–179.99)

0.65 (0.56–0.75)

5.19 (5.07–5.32)

 Low-middle SDI

23.75 (19.78–28.18)

0.21 (0.18–0.25)

82.58 (71.86–95.17)

0.47 (0.41–0.54)

2.84 (2.71–2.97)

 Low SDI

11.02 (8.74–13.48)

0.21 (0.17–0.26)

32.86 (27.61–38.60)

0.29 (0.24–0.34)

1.27 (1.13–1.41)

Region

     

 Andean Latin America

0.35 (0.29–0.44)

0.09 (0.08–0.12)

1.99 (1.54–2.49)

0.31 (0.24–0.39)

4.65 (4.48–4.82)

 Australasia

6.06 (5.50–7.02)

2.99 (2.71–3.46)

15.18 (11.84–19.98)

5.22 (4.07–6.87)

1.55 (1.52–1.58)

 Caribbean

1.48 (1.32–1.63)

0.42 (0.37–0.46)

3.73 (3.09–4.52)

0.79 (0.65–0.96)

2.31 (2.22–2.40)

 Central Asia

2.32 (1.94–2.61)

0.33 (0.28–0.38)

4.94 (4.12–6.00)

0.53 (0.44–0.64)

1.61 (1.51–1.72)

 Central Europe

17.30 (15.70–20.20)

1.41 (1.28–1.64)

64.36 (54.75–78.94)

5.63 (4.79–6.91)

4.99 (4.95–5.03)

 Central Latin America

2.27 (2.03–2.41)

0.14 (0.1–0.15)

9.59 (7.94–11.77)

0.38 (0.32–0.47)

3.43 (3.29–3.57)

 Central Sub-Saharan Africa

0.60 (0.41–0.91)

0.11 (0.07–0.16)

2.94 (1.97–4.26)

0.22 (0.15–0.32)

2.61 (2.44–2.78)

 East Asia

20.22 (15.23–26.47)

0.17 (0.12–0.22)

162.14 (133.32–199.11)

1.10 (0.91–1.35)

7.98 (7.86–8.10)

 Eastern Europe

37.52 (30.60–44.07)

1.66 (1.35–1.95)

74.24 (65.51–84.31)

3.54 (3.12–4.02)

2.85 (2.81–2.89)

 Eastern Sub-Saharan Africa

4.15 (3.18–5.22)

0.22 (0.17–0.27)

12.70 (10.31–15.83)

0.31 (0.25–0.38)

1.27 (1.14–1.41)

 High-income Asia Pacific

4.58 (4.25–5.54)

0.26 (0.24–0.32)

12.67 (10.38–15.68)

0.68 (0.55–0.84)

3.27 (3.17–3.37)

 High-income North America

122.10 (110.16–129.00)

4.35 (3.92–4.59)

207.23 (174.82–255.27)

5.68 (4.80–7.00)

0.41 (0.38–0.44)

 North Africa and Middle East

6.94 (5.50–8.51)

0.20 (0.16–0.25)

31.52 (26.99–37.75)

0.52 (0.44–0.62)

3.40 (3.28–3.52)

 Oceania

0.02 (0.02–0.03)

0.03 (0.02–0.04)

0.05 (0.04–0.07)

0.04 (0.03–0.05)

0.25 (− 0.11–0.62)

 South Asia

26.94 (22.35–32.58)

0.25 (0.20–0.30)

97.47 (82.93–113.40)

0.54 (0.46–0.63)

2.71 (2.59–2.83)

 Southeast Asia

4.31 (3.57–5.25)

0.09 (0.08–0.11)

19.17 (15.35–4.23)

0.28 (0.23–0.36)

3.99 (3.81–4.16)

 Southern Latin America

2.73 (2.37–3.07)

0.55 (0.48–0.62)

6.10 (4.77–7.89)

0.91 (0.71–1.18)

1.25 (1.17–1.32)

 Southern Sub-Saharan Africa

3.78 (3.20–4.34)

0.72 (0.61–0.83)

9.19 (7.91–10.41)

1.17 (1.01–1.32)

1.83 (1.77–1.90)

 Tropical Latin America

3.19 (2.93–3.41)

0.21 (0.19–0.22)

12.64 (11.13–14.69)

0.57 (0.50–0.66)

3.57 (3.45–3.68)

 Western Europe

134.28 (123.30–142.03)

3.49 (3.21–3.69)

275.60 (235.01–338.18)

6.32 (5.39–7.75)

1.79 (1.76–1.82)

 Western Sub-Saharan Africa

4.25 (3.47–4.98)

0.22 (0.18–0.26)

11.23 (8.99–13.34)

0.25 (0.20—0.25)

0.41 (0.27–0.55)

  1. CLL, chronic lymphocytic leukemia; ASIR, age-standardized incidence rate; EAPC, estimated annual percentage changes; SDI, social-demographic index